Interact to see
Advertisement
Advertisement
ARBNX vs MERFX
ARBNX vs MERFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
ARBNX vs. MERFX commentary
Aug 17, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARBNX is a Hold and MERFX is a Hold.
FUNDAMENTALS
Fundamentals
MERFX has more cash in the bank: 2.39B vs. ARBNX (733M). MERFX pays higher dividends than ARBNX: MERFX (1.65) vs ARBNX (0.67). ARBNX was incepted earlier than MERFX: ARBNX (22 years) vs MERFX (37 years). MERFX (1.67) is less costly to investors than ARBNX (1.53). ARBNX is a more actively managed with annual turnover of: 230.00 vs. MERFX (153.00). MERFX has a lower initial minimum investment than ARBNX: MERFX (2500) vs ARBNX (100000). ARBNX (5.48) and MERFX (5.24) have marching annual gain over last year. MERFX return over 5 years is better than : 10.48 vs. ARBNX (5.90).
| ARBNX | MERFX | ARBNX / MERFX | |
| Total Expense Ratio | 1.53 | 1.56 | 98% |
| Annual Report Gross Expense Ratio | 1.53 | 1.67 | 92% |
| Fund Existence | 22 years | 37 years | - |
| Gain YTD | 5.361 | 5.834 | 92% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 100000 | 2500 | 4,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 733M | 2.39B | 31% |
| Annual Yield % from dividends | 0.67 | 1.65 | 41% |
| Returns for 1 year | 5.48 | 5.24 | 105% |
| Returns for 3 years | 8.69 | 9.20 | 95% |
| Returns for 5 years | 5.90 | 10.48 | 56% |
| Returns for 10 years | 12.00 | 24.85 | 48% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SHPCX | 12.71 | 0.09 | +0.71% |
| Saratoga Health & Biotechnology C | |||
| GCINX | 15.50 | 0.06 | +0.39% |
| Green Century MSCI Intl Indx Indvl Inv | |||
| FCUEX | 20.32 | 0.03 | +0.15% |
| NYLI PineStone U.S. Equity Class A | |||
| OEGAX | 28.68 | -0.07 | -0.24% |
| Invesco Discovery Mid Cap Growth A | |||
| MUSBX | 36.64 | -0.13 | -0.35% |
| MFS Blended Research Core Equity B | |||